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Abstract: This short note describes a one-step synthesis of the title compound from 
commercially available starting materials and reports its full spectroscopic  
characterization data. 
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Introduction 
The pharmaceutical and agrochemical industries are under constant pressure to streamline their 
development cycles to provide new chemical entities required to target human diseases and increase 
agricultural output [1]. Despite recent breakthroughs in the areas of biologics and protein engineering 
simple heterocyclic structures still remain principle targets offering rapid modification points, high 
atom to biological activity ratios, and beneficial pharmacological profiles [2–4]. Consequently many 
synthesis endeavors are focused on accessing new heterocyclic derivatives. Recently, we [5,6] and 
others [7] have reviewed the available literature focusing on top-selling drug molecules and were able 
to confirm and analyse the prevalence of small molecular entities containing five- and six-membered 
heterocyclic rings. Amongst the heteroaromatic scaffolds indoles, imidazoles and pyridines were found 
to be most common, whereas pyrrolidines, piperazines and piperidines are most frequently 
encountered in saturated heterocycles. Consequently, it comes with no surprise that chemists in both 
industry and academia continue to seek new entries into highly versatile heterocyclic building blocks 
bearing specific functionalities (i.e., halides, esters, amines, etc.) or distinct hydrogen bonding 
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networks. Over the past ten years one key area of our research has been to devise modern, often  
flow-based routes towards such interesting heterocyclic architectures [8–11].  
In this short note we wish to report on the efficient synthesis of syn-ethyl 1-hydroxy-7-methoxy-
2,3-dihydro-1H-pyrrolo[3,4-b]quinolone-3-carboxylate hydrochloride salt, which represents an 
interesting fused tricyclic system containing several hydrogen bond acceptors and donors.  
Experimental Section 
To a 100 mL round bottom-flask containing 2-chloro-6-methoxyquinoline-3-carboxaldehyde  
(1, 2.21 g, 10 mmol) and glycine ethyl ester hydrochloride (2, 1.39 g, 10 mmol) in acetonitrile (20 mL) 
was added triethylamine (1.4 mL, 10 mmol) in one portion. The resulting suspension was stirred at 
room temperature for 20 h. After evaporation of the solvent the resulting residue was redissolved in 
ethyl acetate and extracted with water (3 × 25 mL). The organic layer was dried over sodium sulfate, 
filtered and evaporated to yield a waxy solid. This material was recrystallised from dichloromethane to 
furnish a pale yellow amorphous solid (3, 1.95 g, 69% yield, Scheme 1). 
 
Scheme 1. Synthesis of syn-ethyl 1-hydroxy-7-methoxy-2,3-dihydro-1H-pyrrolo[3,4-
b]quinolone-3-carboxylate hydrochloride salt 3. 
Initial analysis of the reaction product by LC-MS and high resolution LC-MS had revealed the 
molecular formula to be C15H16N2O4. Furthermore IR spectroscopy indicated the presence of a 
carbonyl stretch (1724.5 cm−1) as well as an amine (3346.8 and 3276.0 cm−1) and a hydroxyl group 
(2619.2 cm−1) consistent with the tricyclic structure proposed for 3. In addition elemental analysis was 
consistent with the proposed HCl salt of the parent compound, and further analysis of the result 
suggest the presence of a hemihydrate species of 3. 
As the reaction product was isolated as a single diastereoisomer (1H NMR) further 2-dimensional 
NMR experiments were used to determine its relative configuration. Crucially, it was found that both 
methine protons on the pyrrolidine moiety show a correlation in the COSY spectrum with the coupling 
constant being measured as J = 2.8 Hz, which is indicative of a long-range coupling. NOESY spectral 
data furthermore revealed a through space coupling of these two methine protons (see Figure 1 and SI 
for details) indicating the presence of the cis-diastereoisomer. By creating an energy-minimised 3D 
model (ChemDraw 3D, PerkinElmer, Waltham, MA, USA) of the free base form of cis-3 the distance 
between these two protons was estimated to be ~3.3 Å. 
It is believed that this conformationally stable diastereoisomer is due to the presence of the 
hydrochloride salt. 
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Figure 1. Assignment of the relative configuration of 3 based on 2D NMR data and a 
modelled 3D structure (free base form). 
Spectroscopic Data  
1H-NMR (600 MHz, DMSO-d6) δ 8.38 (s, 1H), 7.82 (d, J = 9.1 Hz, 1H), 7.46 (d, J = 2.8 Hz, 1H), 7.40 
(dd, J = 9.2, 2.8 Hz, 1H), 5.95 (s, 1H), 5.34 (d, J = 2.8 Hz, 1H), 4.14 (m, 2H), 3.88 (s, 3H), 3.68 (d,  
J = 2.8 Hz, 1H), 1.19 (t, J = 7.1 Hz, 3H). 
13C-NMR (151 MHz, DMSO-d6) δ 173.8 (C), 158.2 (C), 145.4 (C), 142.6 (C), 137.7 (CH), 134.8 (C), 
129.3 (CH), 128.6 (C), 123.2 (CH), 106.4 (CH), 70.7 (CH), 60.9 (CH2), 58.1 (CH), 56.1 (CH3),  
14.6 (CH3). 
IR (neat, HCl-salt) ν 3346.8 (w), 3276.0 (w), 2619.2 (broad), 1724.5 (s), 1624.4 (m), 1499.3 (m), 
1340.9 (m), 1218.3 (s), 1157.4 (s), 1015.8 (s), 876.5 (m), 823.9 (s), 537.9 (m) cm−1. 
LC-MS (ESI) m/z = 289.1 (M+H). HR-MS (ESI) calculated for C15H17N2O4 289.1188, found 289.1201 
(M+H, Δ = 4.5 ppm). 
Elemental analysis: calculated for C15H16N2O4.HCl.0.5H2O C: 53.98%, H: 5.44%, N: 8.39%; measured 
C: 53.75%, H: 5.18%, N: 8.45%. 
Melting range: ~135–140 °C (HCl-salt; CH2Cl2, decomposition). 
Acknowledgments 
Both authors gratefully acknowledge financial support through the Royal Society. 
Author Contributions 
Both authors contributed equally to the research outlined in this paper and the writing of  
the manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest. 
Molbank 2015  M846 (Page 4) 
 
 
References  
1. Scannel, J.W.; Blanckley, A.; Boldon, H.; Warrington, B. Diagnosing the decline in 
pharmaceutical R&D efficiency. Nat. Rev. Drug Disc. 2012, 11, 191–200. 
2. Li, J.J., Ed. Heterocyclic Chemistry in Drug Discovery; Wiley: Hoboken, NJ, USA, 2013; ISBN: 
978-1-118-14890-7. 
3. Silverman, R.B. The Organic Chemistry of Drug Design and Drug Action; Elsevier Academic 
Press: Burlington, MA, USA, 2004; ISBN 978-0126437324. 
4. Wermuth, C.G., Ed. The Practice of Medicinal Chemistry, 3rd ed.; Elsevier Academic Press: 
Waltham, MA, USA, 2008; ISBN: 978-0-12-374194-3. 
5. Baumann, M.; Baxendale, I.R.; Ley, S.V.; Nikbin, N. An overview of the key routes to the best 
selling 5-membered ring heterocyclic pharmaceuticals. Beilstein J. Org. Chem. 2011, 7, 442–495. 
6. Baumann, M.; Baxendale, I.R. An overview of the synthetic routes to the best selling drugs 
containing 6-membered heterocycles. Beilstein J. Org. Chem. 2013, 9, 2265–2319. 
7. Vitaku, E.; Smith, D.T.; Njardarson, J.T. Analysis of the structural diversity, substitution patterns, 
and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 
2014, 57, 10257–10274. 
8. Baumann, M.; Baxendale, I.R.; Ley, S.V.; Smith, C.D.; Tranmer, G.K. Fully automated 
continuous flow synthesis of 4,5-disubstituted oxazoles. Org. Lett. 2006, 8, 5231–5234. 
9. Baumann, M.; Baxendale, I.R.; Ley, S.V. Synthesis of 3-Nitropyrrolidines via dipolar 
cycloaddition reactions using a modular flow reactor. Synlett 2010, 5, 749–752. 
10. Baumann, M.; Baxendale, I.R.; Kirschning, A.; Ley, S.V.; Wegner, J. Synthesis of highly 
substituted nitropyrrolidines, nitropyrrolizines and nitropyrroles via multicomponent-multistep 
sequences within a flow reactor. Heterocycles 2010, 82, 1297–1316. 
11. Baumann, M.; Baxendale, I.R.; Kuratli, C.; Ley, S.V.; Martin, R.E.; Schneider, J. Synthesis of a 
drug-like focused library of trisubstituted pyrrolidines using integrated flow chemistry and batch 
methods. ACS Comb. Sci. 2011, 13, 405–415. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
